Table 4.
The clinicopathologic characteristics of 89 patients with NSCLC treated with platinum-based chemotherapy only in this study
| Characteristics | Number of patients | |||
|---|---|---|---|---|
| Total | ATP7A(-) | ATP7A(+) | P | |
| Age | ||||
| median | 57 | 57 | 57 | |
| range | 31-79 | 35-79 | 31-77 | 0.469 |
| Gender | ||||
| male | 64 | 39 | 25 | |
| female | 25 | 13 | 12 | 0.442 |
| Response to chemo | ||||
| PR | 29 | 24 | 5 | |
| SD+PD | 60 | 28 | 32 | 0.001 |
| Stage | ||||
| III | 48 | 28 | 20 | |
| IV | 41 | 24 | 17 | 0.436 |
| PS | ||||
| 0 | 46 | 29 | 17 | |
| > 0 | 43 | 23 | 20 | 0.361 |
| Histology | ||||
| squamous | 25 | 14 | 11 | |
| adenocarcinoma | 64 | 39 | 25 | 0.67 |
| Grade | ||||
| low | 48 | 28 | 20 | |
| moderate | 27 | 12 | 15 | |
| high | 14 | 12 | 2 | 0.039 |
| CEA status | ||||
| normal | 34 | 18 | 16 | |
| elevated | 55 | 34 | 21 | 0.661 |